‘Warm’ COVID-19 Vaccine Efficacy: More Effective Against COVID-19 Variants of Concern, CSIRO Study Shows

Medicine & Technology Jul 18, 2021

The warm COVID-19 vaccine that the Indian Institute of Science developed has proven efficacy against all present COVID-19 variants of concern, a study showed.

Italy, France, and Spain Join European Countries in Suspending Oxford-Astrazence COVID-19 Vaccine Rollout Due to Blood Clots

Mar 15, 2021

Italy, France, and Spain joined Germany, the Netherlands, Ireland, and more temporarily suspending vaccination rollouts of Oxford-AstraZeneca COVID jabs due to reports of blood clots as a side effect. The World Health Organization stresses that there is no evidence linking the two and urges governments to continue vaccinations.

How the Oxford-AstaZeneca COVID-19 Vaccine is Deployed in England

Jan 04, 2021

The biggest vaccination program in the history of the United Kingdom is getting a major boost today, with the Oxford-AstraZeneca COVID-19 vaccine's initial use.

Oxford-AstraZeneca Vaccine Authorized in UK, 100M Viles Ordered

Dec 31, 2020

Emergency usage begins as UK's COVID-19 strain leads to a spike in hospital admissions worldwide.

UK Developing New COVID-19 Treatment Alternative From Vaccine

Dec 30, 2020

AstraZeneca recruited their first participants as part of a study of a new long-acting COVID-19 antibody treatment.

AstraZeneca Temporarily Stops Phase 3 of Global Vaccine Trials

Sep 09, 2020

AstraZeneca, already in the late-stage of their phase three vaccine trials, had to pause all trials due to one volunteer developing an unexplained illness. Alongside other Operation Warp Speed Companies, the biopharmaceutical company signed a joint pledge to properly follow scientific and ethical standards in developing a coronavirus vaccine.

Oxford-AstraZeneca and CanSino Coronavirus Vaccine Candidates Deemed Safe and Effective

Jul 20, 2020

The Oxford-AstraZeneca and CanSino vaccine candidates have both shown promising results in their early trials. As they now both enter phase three clinical trials, experts are hopeful that the vaccine candidates would continue to produce good results.